• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重启 2019 冠状病毒病大流行时代的呼吸临床研究。

Restarting Respiratory Clinical Research in the Era of the Coronavirus Disease 2019 Pandemic.

机构信息

Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, National Jewish Health, Denver, CO; Department of Pediatrics, National Jewish Health, Denver, CO; Department of Biomedical Research, National Jewish Health, Denver, CO.

Division of Environmental and Occupational Health Sciences, Department of Medicine, National Jewish Health, Denver, CO.

出版信息

Chest. 2021 Mar;159(3):1173-1181. doi: 10.1016/j.chest.2020.11.001. Epub 2020 Nov 13.

DOI:10.1016/j.chest.2020.11.001
PMID:33197402
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7664336/
Abstract

The clinical research we do to improve our understanding of disease and to develop new therapies has temporarily been delayed as the global health-care enterprise has focused its attention on those impacted by coronavirus disease 2019 (COVID-19). Although rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are decreasing in many areas, many locations continue to have a high prevalence of infection. Nonetheless, research must continue and institutions are considering approaches to restarting non-COVID-related clinical investigation. Those restarting respiratory research must navigate the added planning challenges that take into account outcome measures that require aerosol-generating procedures. Such procedures potentially increase risk of transmission of SARS-CoV-2 to research staff, use limited personal protective equipment, and require conduct in negative-pressure rooms. One must also be prepared to address the potential for COVID-19 resurgence. With research subject and staff safety and maintenance of clinical trial data integrity as the guiding principles, here we review key considerations and suggest a step-wise approach for resuming respiratory clinical research.

摘要

我们开展临床研究,旨在加深对疾病的认识并开发新疗法,但由于全球医疗保健机构将重点放在了受 2019 冠状病毒病(COVID-19)影响的人群上,我们的研究暂时被搁置。虽然在许多地区,严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染率正在下降,但许多地方的感染率仍然很高。然而,研究必须继续进行,各机构正在考虑重启与 COVID-19 无关的临床研究的方法。重启呼吸道研究的人员必须应对额外的规划挑战,这些挑战需要考虑需要产生气溶胶的程序的结果测量。这些程序可能会增加 SARS-CoV-2 传播给研究人员的风险,限制个人防护设备的使用,并需要在负压室中进行。还必须准备应对 COVID-19 死灰复燃的可能性。以研究对象和工作人员的安全以及临床试验数据完整性的维护为指导原则,我们在这里审查了关键的注意事项,并提出了逐步恢复呼吸道临床研究的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6796/7664336/09279f986cad/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6796/7664336/09279f986cad/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6796/7664336/09279f986cad/gr1_lrg.jpg

相似文献

1
Restarting Respiratory Clinical Research in the Era of the Coronavirus Disease 2019 Pandemic.重启 2019 冠状病毒病大流行时代的呼吸临床研究。
Chest. 2021 Mar;159(3):1173-1181. doi: 10.1016/j.chest.2020.11.001. Epub 2020 Nov 13.
2
Guidance for otolaryngology health care workers performing aerosol generating medical procedures during the COVID-19 pandemic.COVID-19 大流行期间耳鼻喉科医护人员进行气溶胶产生医疗操作的指南。
J Otolaryngol Head Neck Surg. 2020 Jun 3;49(1):36. doi: 10.1186/s40463-020-00429-2.
3
Insights into laser safety considerations during COVID 19 pandemic.COVID-19 大流行期间激光安全注意事项的新见解。
Dermatol Ther. 2020 Sep;33(5):e13777. doi: 10.1111/dth.13777. Epub 2020 Jul 7.
4
Society of swallowing and dysphagia of Japan: Position statement on dysphagia management during the COVID-19 outbreak.日本吞咽与吞咽困难学会:关于COVID-19疫情期间吞咽困难管理的立场声明。
Auris Nasus Larynx. 2020 Oct;47(5):715-726. doi: 10.1016/j.anl.2020.07.009. Epub 2020 Jul 23.
5
Extent of infectious SARS-CoV-2 aerosolisation as a result of oesophagogastroduodenoscopy or colonoscopy.因食管胃十二指肠镜检查或结肠镜检查导致的传染性严重急性呼吸综合征冠状病毒2气溶胶化程度。
Br J Hosp Med (Lond). 2020 Jul 2;81(7):1-7. doi: 10.12968/hmed.2020.0348. Epub 2020 Jul 6.
6
Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Patients Infected by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2).外科感染学会关于成人严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)感染者手术和围手术期护理的指南。
Surg Infect (Larchmt). 2020 May;21(4):301-308. doi: 10.1089/sur.2020.101. Epub 2020 Apr 20.
7
Surgical Considerations for an Awake Tracheotomy During the COVID-19 Pandemic.2019冠状病毒病大流行期间清醒气管切开术的手术考量
J Laparoendosc Adv Surg Tech A. 2020 May;30(5):477-480. doi: 10.1089/lap.2020.0239. Epub 2020 Apr 20.
8
A Flexible Enclosure to Protect Respiratory Therapists During Aerosol-Generating Procedures.一种用于在产生气溶胶的过程中保护呼吸治疗师的灵活外壳。
Respir Care. 2020 Dec;65(12):1923-1932. doi: 10.4187/respcare.08568.
9
In vitro comparison of surgical techniques in times of the SARS-CoV-2 pandemic: electrocautery generates more droplets and aerosol than laser surgery or drilling.在 SARS-CoV-2 大流行期间的手术技术的体外比较:电灼比激光手术或钻孔产生更多的飞沫和气溶胶。
Eur Arch Otorhinolaryngol. 2021 Apr;278(4):1237-1245. doi: 10.1007/s00405-020-06330-y. Epub 2020 Sep 7.
10
COVID-19 safety: aerosol-generating procedures and cardiothoracic surgery and anaesthesia - Australian and New Zealand consensus statement.COVID-19 安全:气溶胶生成程序与心胸外科手术和麻醉 - 澳大利亚和新西兰共识声明。
Med J Aust. 2021 Jan;214(1):40-44. doi: 10.5694/mja2.50804. Epub 2020 Oct 11.

引用本文的文献

1
Pragmatic Evaluation of an Improvement Program for People Living With Modifiable High-Risk COPD Versus Usual Care: Protocols for the Cluster Randomized PREVAIL Trial.针对可改变的高危慢性阻塞性肺疾病患者的改善计划与常规护理的实用性评估:整群随机PREVAIL试验方案
Chronic Obstr Pulm Dis. 2025 May 27;12(3):223-239. doi: 10.15326/jcopdf.2024.0564.
2
Mixed Th1/Th2/Th17 Responses Induced by Plant Oil Adjuvant-Based Vaccine in Mice, with Mechanisms Unraveled by RNA-Seq, 16S rRNA and Metabolomics.基于植物油佐剂的疫苗在小鼠中诱导的混合Th1/Th2/Th17反应,其机制通过RNA测序、16S rRNA和代谢组学得以阐明。
Vaccines (Basel). 2024 Oct 17;12(10):1182. doi: 10.3390/vaccines12101182.
3
Letter to the Editor: "The impact of COVID-19 pandemic on the initiation of interventional clinical trials conducted in intensive care units".
致编辑的信:“新冠疫情对重症监护病房开展的介入性临床试验启动的影响”
J Crit Care. 2022 Jun;69:154019. doi: 10.1016/j.jcrc.2022.154019. Epub 2022 Mar 12.
4
The future is now: our experience starting a remote clinical trial during the beginning of the COVID-19 pandemic.未来已来:我们在 COVID-19 大流行初期启动远程临床试验的经验。
Trials. 2021 Sep 7;22(1):603. doi: 10.1186/s13063-021-05537-6.